Cargando…

A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin’s Ranibizumab with Lucentis(®) in patients with neovascular age-related macular degeneration

PURPOSE: The present study compares the efficacy, safety, and immunogenicity of Lupin’s biosimilar ranibizumab with that of Lucentis(®) in patients with neovascular age-related macular degeneration. METHODS: This prospective, double-blind, multi-centric phase-III study was conducted across 19 center...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Ramandeep, Chauhan, Rohan, Saxena, Ashish, Shah, Anup, Mondal, Laxshmi, Bakhle, Dhananjay, Shah, Chirag, Shah, Arpit, Deoghare, Shashank, Krishnan, Neelakant, Godse, Neelima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Special Focus, Retina, Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672715/ https://www.ncbi.nlm.nih.gov/pubmed/35918962 http://dx.doi.org/10.4103/ijo.IJO_2118_21

Ejemplares similares

Response to commentary on: A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin’s ranibizumab with Lucentis in patients with neovascular age-related macular degeneration
por: Shah, Chirag, et al.
Publicado: (2023)

Systematic review of efficacy and meta-analysis of safety of ranibizumab biosimilars relative to reference ranibizumab anti-VEGF therapy for nAMD treatment
por: Hatamnejad, Amin, et al.
Publicado: (2023)

Macular functional changes in patients with neovascular age-related macular degeneration receiving ranibizumab therapy (lucentis)
por: Scalzo, G C, et al.
Publicado: (2010)

Commentary:A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin’s ranibizumab with lucentis in patients with neovascular age-related macular degeneration
por: Gopal, Lingam
Publicado: (2022)

Treatment of Radiation Retinopathy with Intravitreal Injection of Ranibizumab (Lucentis(®))
por: Horowitz, Soraya Alessandra, et al.
Publicado: (2020)

Functional benefits of a chorioretinal anastomosis at 2 years in eyes with a central retinal vein occlusion treated with ranibizumab compared with ranibizumab monotherapy
por: McAllister, Ian L, et al.
Publicado: (2021)

Aqueous Fluid Transcriptome Profiling Differentiates Between Non-Neovascular and Neovascular AMD
por: Kaidonis, Georgia, et al.
Publicado: (2023)

Effects of ranibizumab (Lucentis®) and bevacizumab (Avastin®) on human corneal endothelial cells
por: Merz, Patrick R., et al.
Publicado: (2018)

Immunosubunit β5i Knockout Suppresses Neovascularization and Restores Autophagy in Retinal Neovascularization by Targeting ATG5 for Degradation
por: Ji, Liyang, et al.
Publicado: (2020)

Fiji-Assisted Automatic Quantitative Volumetric Analysis of Choroidal Neovascularization in a Laser-Induced Choroidal Neovascularization Mouse Model
por: Pollalis, Dimitrios, et al.
Publicado: (2023)

The Impact of Diabetic Retinopathy on the Choriocapillaris in Neovascular AMD
por: Viggiano, Pasquale, et al.
Publicado: (2023)

Evaluation of the Structural, Physicochemical, and Biological Characteristics of SB11, as Lucentis(®) (Ranibizumab) Biosimilar
por: Kim, Eunji, et al.
Publicado: (2022)

Evaluation of Molecular Properties versus In Vivo Performance of Aflibercept, Brolucizumab, and Ranibizumab in a Retinal Vascular Hyperpermeability Model
por: Schubert, William, et al.
Publicado: (2022)

Detection of Choroidal Neovascularization Using Optical Tissue Transparency
por: Ma, Xiao-Hong, et al.
Publicado: (2023)

Internal limiting membrane peeling for large macular hole: Tailoring the rhexis to the shape of the hole
por: Shukla, Dhananjay, et al.
Publicado: (2022)

Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization
por: Zhang, Hanfang, et al.
Publicado: (2018)

Fursultiamine Alleviates Choroidal Neovascularization by Suppressing Inflammation and Metabolic Reprogramming
por: Do, Ji Yeon, et al.
Publicado: (2020)

Irisin Attenuates Pathological Neovascularization in Oxygen-Induced Retinopathy Mice
por: Zhang, Jieqiong, et al.
Publicado: (2022)

PPARα-Dependent Effects of Palmitoylethanolamide Against Retinal Neovascularization and Fibrosis
por: Ye, Sihao, et al.
Publicado: (2020)

Reduction of Laser-Induced Choroidal Neovascularization in Mice With Erythropoietin RNA Interference
por: Lv, Wenjuan, et al.
Publicado: (2022)

A case of subacute cutaneous lupus erythematosus as a result of ranibizumab (Lucentis) treatment
por: Andric, Marko, et al.
Publicado: (2013)

Comparison of intravitreal injection of ranibizumab versus bevacizumab for treatment of type 1 and aggressive retinopathy of prematurity in rural Egypt. A randomized clinical trial
por: Tawfik, Ghada Mahmoud, et al.
Publicado: (2022)

Classification of Choroidal Neovascularization Using Projection-Resolved Optical Coherence Tomographic Angiography
por: Patel, Rachel, et al.
Publicado: (2018)

The Carnitine Shuttle Pathway is Altered in Patients With Neovascular Age-Related Macular Degeneration
por: Mitchell, Sabrina L., et al.
Publicado: (2018)

Exploring the Relationship Between Multilayered Choroidal Neovascularization and Choriocapillaris Flow Deficits in AMD
por: Nesper, Peter L., et al.
Publicado: (2021)

Relationship Between Drusen Height and OCT Biomarkers of Atrophy in Non-Neovascular AMD
por: Au, Adrian, et al.
Publicado: (2022)

Imaging Histology Correlations of Intraretinal Fluid in Neovascular Age-Related Macular Degeneration
por: Berlin, Andreas, et al.
Publicado: (2023)

Prognostic Evaluation of Vitrectomy Assisted by Lucentis in Diabetic Retinopathy and Neovascular Glaucoma
por: Zhao, Xuli, et al.
Publicado: (2022)

Monocyte-Derived Macrophages Are Necessary for Beta-Adrenergic Receptor-Driven Choroidal Neovascularization Inhibition
por: Droho, Steven, et al.
Publicado: (2019)

Complement Activation Products and Cytokines in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration
por: Kato, Yutaka, et al.
Publicado: (2020)

Bulk Gene Expression Deconvolution Reveals Infiltration of M2 Macrophages in Retinal Neovascularization
por: Wang, Jiang-Hui, et al.
Publicado: (2021)

The Association of Fluid Volatility With Subretinal Hyperreflective Material and Ellipsoid Zone Integrity in Neovascular AMD
por: Ehlers, Justis P., et al.
Publicado: (2022)

Topographical Analysis of the Choriocapillaris Reperfusion After Loading Anti-VEGF Therapy in Neovascular AMD
por: Viggiano, Pasquale, et al.
Publicado: (2022)

Interleukin-19 Promotes Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy
por: Zou, Jingling, et al.
Publicado: (2022)

The Clinical Role of the Choroidal Assessment in High Myopia: Characteristics and Association With Neovascular and Atrophic Complications
por: Arrigo, Alessandro, et al.
Publicado: (2023)

Attenuation of Laser-Induced Choroidal Neovascularization by Blockade of Prostaglandin D(2) Receptor 2
por: Soga, Hirotsugu, et al.
Publicado: (2023)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
por: Shah, Nikunj J, et al.
Publicado: (2011)

A Pharmacodynamic Analysis of Choroidal Neovascularization in a Porcine Model Using Three Targeted Drugs
por: Tran, Jeffrey, et al.
Publicado: (2017)

Optical Coherence Tomography Angiography Quantitative Assessment of Macular Neovascularization in Best Vitelliform Macular Dystrophy
por: Battaglia Parodi, Maurizio, et al.
Publicado: (2020)

A Clinical Metabolite of Azidothymidine Inhibits Experimental Choroidal Neovascularization and Retinal Pigmented Epithelium Degeneration
por: Narendran, Siddharth, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a1lcnp1r33uuu49e981nuvac2q